Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bennion

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Plos Genetics|May 14, 2010
The nuclear receptor DHR3 modulates dS6 kinase-dependent growth in DrosophilaJacques Montagne, Caroline Lecerf, Jean-Philippe Parvy, et al.
Frontiers in Neurology|January 28, 2026
Interaural correlation of acoustic hearing preservation following sequential cochlear implantationArmine Kocharyan, Carolina Chu, Rustin Kashani, et al.
Clinical Science (London, England : 1979)|March 4, 2018
Protective effects of the angiotensin II AT<sub>2</sub> receptor agonist compound 21 in ischemic stroke: a nose-to-brain delivery approachDouglas M Bennion, Chad H Jones, Alex N Dang, et al.
Neuropharmacology|February 11, 2014
The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic strokeJason P Joseph, Adam P Mecca, Robert W Regenhardt, et al.
Experimental Physiology|April 18, 2018
Neuroprotection by post-stroke administration of an oral formulation of angiotensin-(1-7) in ischaemic strokeDouglas M Bennion, Chad H Jones, Lauren L Donnangelo, et al.
Rejuvenation Research|December 30, 2014
Practicality of intermittent fasting in humans and its effect on oxidative stress and genes related to aging and metabolismMartin P Wegman, Michael H Guo, Douglas M Bennion, et al.
Plos One|July 4, 2017
Post-stroke angiotensin II type 2 receptor activation provides long-term neuroprotection in aged ratsDouglas M Bennion, Jacob D Isenberg, Allison T Harmel, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Cochlear implants with dexamethasone-eluting electrode arrays reduce foreign body response in a murine model of cochlear implantation and human subjectsMuhammad Taifur Rahman, Brian Mostaert, Peter Eckard, et al.
Scientific Reports|August 20, 2025
Dexamethasone-eluting cochlear implants reduce inflammation and foreign body response in human and murine cochleaeMuhammad Taifur Rahman, Brian J Mostaert, Peter Eckard, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Plos Genetics|May 14, 2010
The nuclear receptor DHR3 modulates dS6 kinase-dependent growth in DrosophilaJacques Montagne, Caroline Lecerf, Jean-Philippe Parvy, et al.
Frontiers in Neurology|January 28, 2026
Interaural correlation of acoustic hearing preservation following sequential cochlear implantationArmine Kocharyan, Carolina Chu, Rustin Kashani, et al.
Clinical Science (London, England : 1979)|March 4, 2018
Protective effects of the angiotensin II AT<sub>2</sub> receptor agonist compound 21 in ischemic stroke: a nose-to-brain delivery approachDouglas M Bennion, Chad H Jones, Alex N Dang, et al.
Neuropharmacology|February 11, 2014
The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic strokeJason P Joseph, Adam P Mecca, Robert W Regenhardt, et al.
Experimental Physiology|April 18, 2018
Neuroprotection by post-stroke administration of an oral formulation of angiotensin-(1-7) in ischaemic strokeDouglas M Bennion, Chad H Jones, Lauren L Donnangelo, et al.
Rejuvenation Research|December 30, 2014
Practicality of intermittent fasting in humans and its effect on oxidative stress and genes related to aging and metabolismMartin P Wegman, Michael H Guo, Douglas M Bennion, et al.
Plos One|July 4, 2017
Post-stroke angiotensin II type 2 receptor activation provides long-term neuroprotection in aged ratsDouglas M Bennion, Jacob D Isenberg, Allison T Harmel, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Cochlear implants with dexamethasone-eluting electrode arrays reduce foreign body response in a murine model of cochlear implantation and human subjectsMuhammad Taifur Rahman, Brian Mostaert, Peter Eckard, et al.
Scientific Reports|August 20, 2025
Dexamethasone-eluting cochlear implants reduce inflammation and foreign body response in human and murine cochleaeMuhammad Taifur Rahman, Brian J Mostaert, Peter Eckard, et al.
Pageof 3